Monday | Applied Clinical Trials
CardioDx Announces Publication of the IMPACT-CARD Trial Demonstrating ...
CardioDx Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus? CAD Test Influenced Cardiologists' Clinical Management of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease CardioDx Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus CAD Test Influenced Cardiologists' Clinical ... (more)
CardioDx Announces New Data Demonstrating Use of Corus? CAD in the...
CardioDx Announces New Data Demonstrating Use of Corus CAD in the Primary Care Setting for Evaluation of Symptomatic Patients with Suspected CAD Influences Clinical Decision Making /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics , today announced results of a clinical utility study of the Corus CAD gene ... (more)
CardioDx to Present at the 12th Annual Needham Healthcare Conference
CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics , today announced that the company will present at the 12th Annual Needham Healthcare Conference on Tuesday, April 30, 2013 at 9:40 AM ET at the Westin Grand Central Hotel in New York.